Chronic Kidney Disease News

Among patients with type 2 diabetes and chronic kidney disease, finerenone treatment may provide cardiovascular benefits, according to data published in the Clinical Journal of the American Society of Nephrology.

Compared with glucagon-like peptide-1 receptor agonists, patients with chronic kidney disease and type 2 diabetes experienced increased risks when taking SGLT2 inhibitors, according to published data.

Among patients with type 2 diabetes and albuminuric chronic kidney disease, canagliflozin reduced kidney and cardiovascular events independent of age or sex, according to data published in the American Journal of Kidney Diseases.

Older adults with chronic kidney disease are at an increased risk for major hemorrhage, according to data published in Kidney International.

Among patients with chronic kidney disease, the presence of metabolic acidosis is associated with an increased risk of adverse kidney outcomes and health care costs, according to data published in Kidney Medicine.

Among patients with chronic kidney disease, heart failure with preserved ejection fraction was highly prevalent, according to data published in Kidney Medicine.

A survey conducted by Bayer reveals physicians agree there is a need for earlier testing and more transparent communication with patients who have chronic kidney disease associated with type 2 diabetes.

The presence of kidney lesions correlates with a risk for heart disease in patients who have chronic kidney disease, according to data published in JAMA Cardiology.

Editor’s note: Healio/Nephrology News & Issues interviewed Bernard Jaar, MD, chairperson of the National Kidney Foundation’s Spring Clinical Meetings, which take place April 11-15 in Austin, Texas. For more information and to register for the meeting, visit www.kidney.org/spring-clinical.

The National Kidney Foundation has named Melanie P. Hoenig, MD, a Harvard Medical School educator and nephrologist, the 2023 winner of the Donald W. Seldin Award, according to a press release.